TENX - TENAX THERAPEUTICS, INC.
14.51
3.490 24.052%
Share volume: 2,124,757
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$11.02
3.49
0.32%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-25-2025 | 05-14-2025 | 08-13-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 14.460 M | 10.617 M | 99.785 M | 96.686 M | 112.059 M | 105.857 M | 102.810 M | |
| Current Assets | 14.459 M | 10.616 M | 99.784 M | 96.686 M | 112.059 M | 105.857 M | 102.810 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 66.625 K | 50.250 K | 33.875 K | 64.000 K | 88.000 K | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 12.549 M | 9.384 M | 98.311 M | 94.851 M | 111.447 M | 105.462 M | 99.369 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 1.117 K | 1.117 K | 1.117 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 14.460 M | 10.617 M | 99.785 M | 96.686 M | 112.059 M | 105.857 M | 102.810 M | |
| Total liabilities | 2.031 M | 1.741 M | 2.562 M | 4.693 M | 2.768 M | 2.527 M | 6.599 M | |
| Total current liabilities | 2.031 M | 1.741 M | 2.562 M | 4.693 M | 2.768 M | 2.527 M | 6.599 M | |
| Accounts Payable | 1.081 M | 869.656 K | 1.584 M | 3.157 M | 1.839 M | 562.000 K | 5.608 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.429 M | 8.876 M | 97.223 M | 91.993 M | 109.291 M | 103.330 M | 96.211 M | |
| Common stock | 313.481 M | 313.503 M | 405.811 M | 406.848 M | 434.554 M | 439.440 M | 448.125 M | |
| Retained earnings | -301.052 M | -304.627 M | -308.588 M | -314.855 M | -325.263 M | -336.110 M | -351.914 M |